Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label markman. Show all posts
Showing posts with label markman. Show all posts
Friday, April 20, 2012

Medscape: (Avastin) Bevacizumab: First-Line Therapy in Ovarian Cancer?: Evidence for First-Line Therapy Dr's Markman, Burger, Swenterton

›
Bevacizumab: First-Line Therapy in Ovarian Cancer?: Evidence for First-Line Therapy Editor’s Note:   Two phase ...
Wednesday, March 28, 2012

reposted from Jan 2012 - worth reading - Editorial Commentary - Maurie Markman - Clinical Oncology News - Meaningful Responses To ‘We-Know-the-Answer’ Syndrome

›
".... The following three examples, all drawn from the field of epithelial ovarian cancer management , illustrate the dangers of sim...
Wednesday, March 21, 2012

Case Reports in Oncology - Journal Home (Editor: M. Markman - open access journal)

›
Case Reports in Oncology - Journal Home Editor(s): Markman M.   (Philadelphia, Pa.) ...
Tuesday, March 20, 2012

REPOST: CA-125: To Monitor or Not to Monitor?: Evidence Against Monitoring CA-125

›
 Blogger's Note: Medscape requires registration (free) CA-125: To Monitor or Not to Monitor?: Evidence Against Monitoring CA-125   F...
Thursday, March 08, 2012

open access: Nature Reviews: Key Advances in Medicine - Ovarian Cancer/Markman page 15-16

›
Key Advances in Medicine (book) Nature Reviews Clinical Oncology  (page 15)S11 ovarian cancer | Mutations and non-inferiority analyses s...
Wednesday, August 17, 2011

Clinical Oncology News - The Concept of ‘Unrealistic Optimism’ In Early-Phase Trials (Markman) - Aug issue

›
"Oncologists may not be fully aware of a relatively new term introduced by ethicists to describe certain patients who agree to particip...
Monday, July 04, 2011

Gynecologic Oncology: Highlights From Asco 2011

›
Wednesday, June 15, 2011

overview ASCO text + video: Bevacizumab: The Sleeping Giant in Ovarian Cancer (maintenance, PARPs, mutations/genetics/molecular testing/genetic profiles/screening/single agent Avastin/ICON7....)

›
Bevacizumab: The Sleeping Giant in Ovarian Cancer Maurie Markman, MD; Gini Fleming, MD Posted: 06/13/2011
Saturday, May 21, 2011

Markman commentary: Can weekly topotecan substitute for a multi-day regimen in the treatment of ovarian cancer? Sadly, 10 years later the answer remains unknown

›
Gynecologic Oncology Article in Press doi:10.1016/j.ygyno.2011.04.020  |  How to Cite or Link Using DOI C...
Saturday, April 23, 2011

Oncology - Interpreting Clinical Trial Results - Clinical Options in Practice

›
Note: requires registration (free) ; worth reading Oncology - Interpreting Clinical Trial Results Auth...
Friday, March 18, 2011

March 11/2011 Dr Maurie Markman: Prophylactic Oophorectomy and BRCA1/2 Mutations

›
Note : full free access/requires registration excerpt:  "Short- and Long-Term Effects of Surgical Menopause Second, the performance o...
Friday, December 31, 2010

Clinical Care Options website: update includes Avastin - Ovarian Cancer

›
Note: full free access (requires free registration) Authors: Maurie Markman, MD Released: 11/17/10 Last Reviewed: 12/2/10 ( What...
Sunday, October 10, 2010

short video: commentary Dr Maurie Markman - Neoadjuvant Chemotherapy for Advanced Ovarian Cancer

›
Wednesday, August 18, 2010

Continued Uncertainty Regarding Hyperthermic Intraperitoneal Chemotherapy in Malignant Peritoneal Mesothelioma -- Markman 28 (24): e418 -- Journal of Clinical Oncology

›
Monday, June 28, 2010

Reply to M. Markman -- Ferrandina 28 (19): e321 -- Journal of Clinical Oncology

›
Markman:  Serious Ethical Dilemma of Single-Agent Pegylated Liposomal Doxorubicin Employed As a Control Arm in Ovarian Cancer Chemotherapy...

Serious Ethical Dilemma of Single-Agent Pegylated Liposomal Doxorubicin Employed As a Control Arm in Ovarian Cancer Chemotherapy Trials -- Markman JCO commentary

›
"... It is essential that those reading this letter do not misinterpret its meaning. There is absolutely no intent in this discussion ...
Wednesday, May 05, 2010

The role of initial maximal surgical cytoreduction in ovarian cancer still debated Dr Maurie Markman Editorial

›
"Although the world of surgery is not necessarily characterized by the utility of innovative clinical hypotheses being formally evaluat...
Tuesday, March 30, 2010

Clinical Care Options - CME - Dr Maurie Markman updated CME March 3, 2010

›
Note: requires Password/Registration (free): Oncology - Ovarian Cancer Authors: Maurie Markman, MD Date Released: October 01, 2009 Las...
Friday, February 12, 2010

Maurie Markman, MD, explains his passion for gynecologic cancer research | HemOncToday

›
excerpts from article: "What is the best advice you’ve ever received? My earliest mentor was my family physician/internist, who...